New UCLA research finds that 30% of people treated for COVID-19 developed Post Acute Sequelae of COVID-19 (PASC), most commonly known as "Long COVID." People with a history of hospitalization, diabetes, and higher body mass ...
Apr 19, 2022
0
223
(HealthDay)—Obese people have a tougher time fighting COVID-19, even if they have a milder form of the virus, a new study finds.
Oct 20, 2021
0
23
The effects of COVID-19 on the lungs are well-known. As the COVID-19 pandemic continues, more information is becoming available about the role the virus, called SARS-CoV-2, has on the heart. "Individuals with known cardiovascular ...
Apr 7, 2020
0
6
Secondhand exposure at home to the nicotine vapor from e-cigarettes is linked to a heightened risk of bronchitic symptoms and shortness of breath among young adults, finds research published online in the respiratory journal ...
Jan 10, 2022
0
67
(HealthDay) -- Parents should not use benzocaine products to relieve teething pain in babies except under the advice and supervision of a health care professional, the U.S. Food and Drug Administration says.
Jul 29, 2012
0
1
According to a study published today in Blood Advances, people suffering from long COVID may face an increased risk of abnormal blood clotting. Investigators also found that this blood abnormality was four times more likely ...
May 11, 2022
0
110
(Medical Xpress)—A study led by a Michigan State University researcher offers the strongest evidence yet that reflexology – a type of specialized foot massage practiced since the age of pharaohs – can help cancer patients ...
Nov 13, 2012
0
0
Researchers in Baltimore have identified new compounds whichrelax airway muscles and may provide relief from shortness of breath for patients with COPD and asthma. The bitter-tasting compounds are at least as, if not more, ...
May 15, 2011
0
0
(HealthDay)—The gout medicine Uloric (febuxostat) carries a higher risk of death than allopurinol, according to the U.S. Food and Drug Administration.
Feb 25, 2019
0
19
(HealthDay)—Vyvgart (efgartigimod), a neonatal Fc receptor blocker (FcRn), was approved to treat generalized myasthenia gravis in adults who test positive for the anti-acetylcholine receptor (AChR) antibody, the U.S. Food ...
Dec 21, 2021
0
6
